Clinical optimal dose of solifenacin succinate for nursing patients after transurethral resection of the prostate during the perioperative period.

about

Clinical optimal dose of solifenacin succinate for nursing patients after transurethral resection of the prostate during the perioperative period.

Item

http://www.wikidata.org/entity/Q49457765

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical optimal dose of solif ...... ring the perioperative period.

@en

Clinical optimal dose of solif ...... ring the perioperative period.

@nl

type

Item

label

Clinical optimal dose of solif ...... ring the perioperative period.

@en

Clinical optimal dose of solif ...... ring the perioperative period.

@nl

prefLabel

Clinical optimal dose of solif ...... ring the perioperative period.

@en

Clinical optimal dose of solif ...... ring the perioperative period.

@nl

P1476

Clinical optimal dose of solif ...... ring the perioperative period.

@en

P2093

Baodi Zhang

http://www.w3.org/2001/XMLSchema#string

Hongdan Huo

http://www.w3.org/2001/XMLSchema#string

Jia Wei

http://www.w3.org/2001/XMLSchema#string

Junrong Wang

http://www.w3.org/2001/XMLSchema#string

Lei Wang

http://www.w3.org/2001/XMLSchema#string

Xuan Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Acupuncture for benign prostatic hyperplasia: a systematic review protocol

A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia

Repetitive prostatic massage and drug therapy as an alternative to transurethral resection of the prostate.

Thulium laser enucleation of the prostate (TmLEP) vs. transurethral resection of the prostate (TURP): evaluation of early results.

Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.

Diagnosis and treatment of benign prostate hyperplasia in Asia.

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder.

Medical management of benign prostatic hyperplasia: Results from a population-based study.

P304

1660-1665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.5567

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434751

http://www.w3.org/2001/XMLSchema#string

P932

5774461

http://www.w3.org/2001/XMLSchema#string